Abstract Objective The transition from screen-film to digital mammography may have altered diagnostic evaluation of women following a positive screening examination. This study compared use and timeliness of diagnostic imaging and biopsy for women screened with screen-film or digital mammography. Materials and Methods Data were from 35, positive screening mammograms on 32, women aged 40—89 years, from 22 Breast Cancer Surveillance Consortium facilities in — Diagnostic pathways were classified by their inclusion of diagnostic mammography, ultrasound, magnetic resonance imaging MRI , and biopsy. We compared time to resolution and frequency of diagnostic pathways by patient characteristics, screening exam modality, and radiology facility. Between-facility differences were evaluated by computing the proportion of mammograms receiving follow-up with a particular pathway for each facility and examining variation in these proportions across facilities.
Mammography and Breast Imaging Resources | American College of Radiology
With any screening modality, the primary point of controversy lies not with the screening but with the cost of follow-up, e. In breast cancer, declining mortality rates have bolstered the use of mammography as a screening tool. However, recent revision to the guidelines for screening mammography have created a firestorm of debate over the cost associated with following-up suspicious lesions for more see the Guest Editorial in this issue on page 4. In the quest to determine who should be biopsied, several modalities have emerged and this article addresses recent literature in an attempt to provide a glimpse of the options that exist to better characterize suspicious breast lesions.
Digital images appear in seconds on a computer screen, revealing an exciting new world of diagnostic possibilities. It is your strongest ally in the fight against breast cancer. Learn about 3D digital mammography here.
Corresponding author. Tel: , Fax: , ca. This article has been cited by other articles in PMC. Abstract An imaging-guided core needle biopsy has been proven to be reliable and accurate for the diagnosis of both benign and malignant diseases of the breast, and has replaced surgical biopsy.